Cyclooxygenase inhibitors and thalidomide ameliorate vincristine-induced hyperalgesia in rats

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2004-07-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00280-004-0809-yPMID 15235822
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Managing Cancer-Related Anorexia/Cachexia

  2012cited by this paper
• Long term effects of vincristine on the peripheral nervous system

  2005cited by this paper
• Taxol‐induced sensory disturbance is characterized by preferential impairment of myelinated fiber function in cancer patients

  2004cited by this paper
• Weight bearing as a measure of disease progression and efficacy of anti-inflammatory compounds in a model of monosodium iodoacetate-induced osteoarthritis.

  2003cited by this paper
• Tumor Necrosis Factor-α Induces Mechanical Allodynia after Spinal Nerve Ligation by Activation of p38 MAPK in Primary Sensory Neurons

  2003cited by this paper
• Changes in sensory processing in the spinal dorsal horn accompany vincristine‐induced hyperalgesia and allodynia

  2003influential reference
• Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons.

  2003cited by this paper
• Suppressive effect of selective cyclooxygenase-2 inhibitor on cytokine release in human neutrophils.

  2003cited by this paper
• Mid-axonal tumor necrosis factor-alpha induces ectopic activity in a subset of slowly conducting cutaneous and deep afferent neurons.

  2002cited by this paper
• Distinct Roles for Cyclooxygenases 1 and 2 in Interleukin-1-Induced Behavioral Changes

  2002cited by this paper
• The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing.

  2002cited by this paper
• Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury.

  2002cited by this paper
• Nitric oxide synergistically potentiates interleukin-1 beta-induced increase of cyclooxygenase-2 mRNA levels, resulting in the facilitation of substance P release from primary afferent neurons: involvement of cGMP-independent mechanisms.

  2002cited by this paper
• Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain

  2002cited by this paper
• Expression and regulation of interleukin-1 receptors in the brain. Role in cytokines-induced sickness behavior.

  2002cited by this paper
• Complete resolution of reflex sympathetic dystrophy with thalidomide treatment.

  2001cited by this paper
• Inhibition of NF-κB Activity by Thalidomide through Suppression of IκB Kinase Activity*

  2001cited by this paper
• Adjuvant-induced arthritis: IL-1β, IL-6 and TNF-α are up-regulated in the spinal cord

  2001cited by this paper
• Simple Screening Tests for Peripheral Neuropathy in the Diabetes Clinic

  2001cited by this paper
• Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

  2001cited by this paper
• Cyclooxygenase-1 vs. cyclooxygenase-2 inhibitors in the induction of antinociception in rodent withdrawal reflexes.

  2001cited by this paper
• Pro- and anti-inflammatory cytokine gene expression in rat sciatic nerve chronic constriction injury model of neuropathic pain.

  2001cited by this paper
• Vincristine‐induced allodynia in the rat

  2001cited by this paper
• A new model of sciatic inflammatory neuritis (SIN): induction of unilateral and bilateral mechanical allodynia following acute unilateral peri‐sciatic immune activation in rats

  2001cited by this paper
• Inhibition of NF-kappa B activity by thalidomide through suppression of IkappaB kinase activity.

  2001cited by this paper
• Adjuvant-induced arthritis: IL-1 beta, IL-6 and TNF-alpha are up-regulated in the spinal cord.

  2001cited by this paper
• Effect of thalidomide on chemokine production by human microglia.

  2000cited by this paper
• Simple screening tests for peripheral neuropathy in the diabetes clinic.

  2000cited by this paper
• Epineurial application of TNF elicits an acute mechanical hyperalgesia in the awake rat

  2000cited by this paper
• Patterns of quantitative sensation testing of hypoesthesia and hyperalgesia are predictive of diabetic polyneuropathy: a study of three cohorts. Nerve growth factor study group.

  2000cited by this paper
• Thalidomide: current and potential clinical applications.

  2000cited by this paper
• Microtubule-interfering Agents Stimulate the Transcription of Cyclooxygenase-2

  2000cited by this paper
• A Neuroimmune Interaction in Painful Peripheral Neuropathy

  2000influential reference
• Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor‐&agr;, increases interleukin‐10 and has long‐term effects on spinal cord dorsal horn met‐enkephalin

  2000influential reference
• Neurochemical plasticity in persistent inflammatory pain.

  2000cited by this paper
• The Role of Pro‐ and Antiinflammatory Cytokines in Neurodegeneration

  2000cited by this paper
• Effect of taxol and taxotere on gene expression in macrophages: induction of the prostaglandin H synthase-2 isoenzyme.

  1999cited by this paper
• Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles.

  1999cited by this paper
• Does a neuroimmune interaction contribute to the genesis of painful peripheral neuropathies?

  1999cited by this paper
• Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats.

  1999cited by this paper
• Hyperalgesia due to nerve injury: role of prostaglandins.

  1999cited by this paper
• The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve

  1998cited by this paper
• Microtubule disorientation and axonal swelling in unmyelinated sensory axons during vincristine‐induced painful neuropathy in rat

  1998cited by this paper
• Nociceptor Hyper-Responsiveness during Vincristine-Induced Painful Peripheral Neuropathy in the Rat

  1998cited by this paper
• Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1beta in the rat.

  1997cited by this paper
• Anorexia, weight loss and increased plasma interleukin-6 caused by chronic intracerebroventricular infusion of interleukin-1 β in the rat

  1997cited by this paper
• Tumour necrosis factor-α induces ectopic activity in nociceptive primary afferent fibres

  1997cited by this paper
• Tumour necrosis factor-alpha induces ectopic activity in nociceptive primary afferent fibres.

  1997cited by this paper
• Vincristine hyperalgesia in the rat: a model of painful vincristine neuropathy in humans.

  1996cited by this paper
• Pain in ambulatory AIDS patients. I: Pain characteristics and medical correlates

  1996cited by this paper
• FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral sphingomyelinase.

  1996cited by this paper
• Inflammatory pain hypersensitivity mediated by phenotypic switch in myelinated primary sensory neurons

  1996cited by this paper
• Components of variance for vibratory and thermal threshold testing in normal and diabetic subjects.

  1995cited by this paper
• GFAP expression in lumbar spinal cord of naive and neuropathic rats treated with MK-801.

  1994cited by this paper
• Acute and conditioned hyperalgesic responses to illness

  1994cited by this paper
• Neurocircuitry of illness-induced hyperalgesia.

  1994cited by this paper
• Characterization of cytokine-induced hyperalgesia.

  1994cited by this paper
• An electrophysiological study of dorsal horn neurons in the spinal cord of rats with an experimental peripheral neuropathy.

  1993cited by this paper
• Thalidomide exerts its inhibitory action on tumor necrosis factor alpha by enhancing mRNA degradation

  1993cited by this paper
• Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs.

  1993cited by this paper
• Responses of spinothalamic tract cells to mechanical and thermal stimulation of skin in rats with experimental peripheral neuropathy.

  1992cited by this paper
• Onset of a painful peripheral neuropathy in rat: a partial and differential deafferentation and spontaneous discharge in A beta and A delta primary afferent neurons.

  1992cited by this paper
• Increased production of interleukin-1 and tumor necrosis factor by human monocytes treated in vitro with cisplatin or other biological response modifiers.

  1992cited by this paper
• An experimental model for peripheral neuropathy produced by segmental spinal nerve ligation in the rat

  1992cited by this paper
• Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

  1991cited by this paper
• Production of interleukin-1 and tumor necrosis factor by cisplatin-treated murine peritoneal macrophages.

  1991cited by this paper
• Chemotherapy amplifies production of tumor necrosis factor.

  1991cited by this paper
• Stimulation of human interleukin 1 production and specific mRNA expression by microtubule-disrupting drugs.

  1990cited by this paper
• A novel behavioral model of neuropathic pain disorders produced in rats by partial sciatic nerve injury

  1990cited by this paper
• Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a population-based survey.

  1988cited by this paper
• A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man

  1988cited by this paper
• Predominantly sensory neuropathy in patients with AIDS and AIDS‐related complex

  1988cited by this paper
• Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve

  1987cited by this paper
• A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

  1987cited by this paper
• Axonal transport disturbances in vincristine‐induced peripheral neuropathy

  1977cited by this paper
• Neurotoxicity of commonly used antineoplastic agents (first of two parts).

  1974cited by this paper
• Neurotoxicity of commonly used antineoplastic agents (second of two parts).

  1974cited by this paper
• Vincristine neuropathy. Clinical and electrophysiological observations.

  1973cited by this paper
• Vincristine treatment of advanced cancer: a cooperative study of 392 cases.

  1973cited by this paper
• The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies.

  1970cited by this paper
• Neurofibrillary degeneration induced by vincristine therapy.

  1969cited by this paper
• Vincristine‐induced neuropathy

  1969cited by this paper

• DRG Voltage-Gated Sodium Channel 1.7 Is Upregulated in Paclitaxel-Induced Neuropathy in Rats and in Humans with Neuropathic Pain

  2017cites this paper
• Novel Small Molecule &agr;9&agr;10 Nicotinic Receptor Antagonist Prevents and Reverses Chemotherapy-Evoked Neuropathic Pain in Rats

  2012cites this paper
• Chemotherapy-induced neuropathic pain

  2011cites this paper
• Impaired glial glutamate uptake induces extrasynaptic glutamate spillover in the spinal sensory synapses of neuropathic rats.

  2010cites this paper
• Minocycline prevents impaired glial glutamate uptake in the spinal sensory synapses of neuropathic rats.

  2010cites this paper
• Étude comparative de trois modèles de douleurs neuropathiques chez le rat : étude comportementale, pharmacologique et analyse transcriptomique.

  2009cites this paper
• Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia

  2009cites this paper
• Models and mechanisms of hyperalgesia and allodynia.

  2009cites this paper
• Animal models of chemotherapy-evoked painful peripheral neuropathies

  2009cites this paper
• Ghrelin prevents cisplatin-induced mechanical hyperalgesia and cachexia.

  2008cites this paper
• Effect of cyclooxygenase and nitric oxide synthase inhibitors on vincristine induced hyperalgesia in rats.

  2008cites this paper
• Chemotherapy‐evoked neuropathic pain: Abnormal spontaneous discharge in A‐fiber and C‐fiber primary afferent neurons and its suppression by acetyl‐l‐carnitine

  2008cites this paper
• Serotonin 5‐HT2A receptor involvement and Fos expression at the spinal level in vincristine‐induced neuropathy in the rat

  2008cites this paper
• Experimental studies of potential analgesics for the treatment of chemotherapy-evoked painful peripheral neuropathies.

  2008cites this paper
• Effect of Gosha-jinki-gan on vincristine-induced painful neuropathy in mice

  2008cites this paper
• Dysfunction in multiple primary afferent fiber subtypes revealed by quantitative sensory testing in patients with chronic vincristine-induced pain.

  2007cites this paper
• The Pathophysiology of Neuropathic Pain: A Review of Current Research and Hypotheses

  2007cites this paper
• Chronic pain in the cancer survivor: a new frontier.

  2007cites this paper
• 71 IMMUNOMODULATORY AGENTS FOR NEUROPATHIC PAIN SYNDROMES: FROM ANIMALS TO CRPS AND BEYOND

  2006cites this paper
• Clinical and experimental findings in humans and animals with chemotherapy-induced peripheral neuropathy.

  2006cites this paper